Comparison of adverse events at 8 weeks between patients who received FMT-AID versus those who received optimised SMT
| FMT-AID (n=35) | SMT (n=31) | P value | |
| Pain abdomen | 11 (31.4) | 17 (54.8) | 0.06 |
| Bloating/flatulence | 17 (48.6) | 12 (38.7) | 0.42 |
| Nausea/vomiting | 4 (11.4) | 4 (12.9) | 0.86 |
| Diarrhoea | 13 (37.1) | 11 (35.5) | 0.89 |
| Fever | 1 (2.9) | 3 (9.7) | 0.25 |
| Worsening of disease activity | 10 (28.6) | 14 (45.2) | 0.16 |
| Hospitalisation | 0 | 0 | – |
| Death | 0 | 0 | – |
| Any adverse events | 26 (74.3) | 27 (87.1) | 0.19 |
| Serious adverse events | 0 | 0 | – |
| Serious infection | 0 | 0 | – |
Numbers in bracket indicate percentage.
FMT-AID, faecal microbiota transplantation and anti-inflammatory diet; SMT, standard medical therapy.